Global Cervical Cancer Diagnostic Testing Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Becton, Dickinson and Co. | Technavio

Technavio has announced its latest market research report titled Global Cervical Cancer Diagnostic Testing Market 2020-2024 (Graphic: Business Wire)

LONDON--()--The cervical cancer diagnostic testing market is poised to grow by USD 2.13 billion during 2020-2024, progressing at a CAGR of almost 7% during the forecast period. Request free sample pages

Read the 127-page report with TOC on "Cervical Cancer Diagnostic Testing Market Analysis Report by Product (Pap smear test and HPV testing), Technology (ELISA, FISH, NASBA, PCR, Multichromatic staining and microscopy), End-user (Hospitals, Clinical diagnostic laboratories, and Others), and Geography (North America, Europe, APAC, South America, and MEA), and the Segment Forecasts, 2020-2024".

https://www.technavio.com/report/global-cervical-cancer-diagnostic-testing-market-industry-analysis

The market is driven by the increased adoption of HPV home testing kits. In addition, the presence of favorable reimbursement policies is anticipated to boost the growth of the cervical cancer diagnostic testing market.

Market vendors are developing various innovative home-based products that provide quick and accurate test results. This will help in reducing the cost for patients thereby facilitating in the prevention and managment of cervical cancer. For instance, the development of products such as the At-home HPV testing kit by Breakspear Medical and careHPV test by QIAGEN has enabled people to perform cervical cancer diagnostic tests at home and has increased the number of people undergoing cervical cancer diagnostic testing. Thus, the increasing focus of various conglomerate companies on developing cervical cancer home testing kits that are cost-efficient and accurate will drive the market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Cervical Cancer Diagnostic Testing Market Companies:

Abbott Laboratories

The company operates in key business segments including Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers a range of cervical cancer diagnostic testing products such as Abbott RealTime High Risk HPV.

Becton, Dickinson and Co.

The company operates in key business segments including Medical, Life Sciences, and Interventional. The company offers a range of cervical cancer diagnostic testing products such as BD Totalys system.

bioMérieux SA

The company offers a range of cervical cancer diagnostic testing products such as NucliSENS EasyQ HPV, through its in vitro diagnostic segment.

Bio-Rad Laboratories Inc.

The company offers a wide range of pharmaceutical and biotechnology oriented solutions through key business segments including Life Science and Clinical Diagnostics. The company offers a range of cervical cancer diagnostic testing products such as AmpliTrol HPV.

Cardinal Health Inc.

The company offers services and solutions through the Pharmaceutical and Medical business segments. The company offers a range of cervical cancer diagnostic testing products such as SafeTex Classic Pap Smear Test Kits.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Cervical Cancer Diagnostic Testing Market Product Outlook (Revenue, USD Billion, 2020-2024)

  • Pap smear test - size and forecast 2019-2024
  • HPV testing - size and forecast 2019-2024

Cervical Cancer Diagnostic Testing Market Technology Outlook (Revenue, USD Billion, 2020-2024)

  • ELISA - size and forecast 2019-2024
  • FISH - size and forecast 2019-2024
  • NASBA - size and forecast 2019-2024
  • PCR - size and forecast 2019-2024
  • Multichromatic staining and microscopy - size and forecast 2019-2024

Cervical Cancer Diagnostic Testing Market End-user Outlook (Revenue, USD Billion, 2020-2024)

  • Hospitals - size and forecast 2019-2024
  • Clinical diagnostic laboratories - size and forecast 2019-2024
  • Others - size and forecast 2019-2024

Cervical Cancer Diagnostic Testing Market Geographic Outlook (Revenue, USD Billion, 2020-2024)

  • North America - size and forecast 2019-2024
  • Europe - size and forecast 2019-2024
  • APAC - size and forecast 2019-2024
  • South America - size and forecast 2019-2024
  • MEA - size and forecast 2019-2024
  • Key leading countries

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Release Summary

The cervical cancer diagnostic testing market size has the potential to grow by USD 2.13 billion during 2020-2024

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/